NCT00016081View on ClinicalTrials.gov

Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1998

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Infection
Interventions
DRUG

ribavirin

Trial Locations (4)

35233

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

63110

Siteman Cancer Center, St Louis

60637-1470

University of Chicago Cancer Research Center, Chicago

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00016081 - Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation | Biotech Hunter | Biotech Hunter